Fig. 8From: Maternal colonization with group B Streptococcus and antibiotic resistance in China: systematic review and meta-analysesAntimicrobial resistance trends reported by China Antimicrobial Resistance Surveillance System (2017 to 2021). Resistance rates of Group B streptococcus to erythromycin, clindamycin, and levofloxacin all showed a slow decreasing trend from 2018 to 2020. However, Group B streptococcus resistance rates to all 3 antimicrobial drugs increased slightly in 2021Back to article page